Minims (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims, is a local anesthetic presented as an ophthalmic solution (eye drops) for topical ocular use. It provides temporary numbness of the eye surface for diagnostic procedures, minor surgery, foreign body removal, and pain relief during examinations, acting by reversible blockade of voltage‑gated sodium channels in ocular nerve fibers.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tetracaine Hydrochloride is a topical ocular anesthetic used to numb the surface of the eye.

Diagnostic ocular procedures: provides temporary anesthesia for slit‑lamp examination, tonometry, and other eye assessments. Minor eye surgery: facilitates painless performance of procedures such as cataract extraction or laser treatment. Foreign body removal: numbs the ocular surface to allow safe extraction of debris. Pain relief during examinations: reduces discomfort during routine eye checks.

Adverse reactions may occur following ocular administration of tetracaine hydrochloride.

Common Side Effects: - Transient stinging or burning sensation at the application site. - Mild redness or conjunctival hyperemia. - Temporary blurred vision or tearing. - Mild allergic conjunctivitis.

Serious or Rare Side Effects: - Corneal ulceration or epithelial defect. - Severe allergic reaction, including anaphylaxis. - Vision loss or persistent visual disturbance. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Careful consideration of patient factors and proper handling can reduce risks associated with tetracaine ophthalmic solution.

Allergy assessment: avoid use in patients with known hypersensitivity to tetracaine or other ester anesthetics. Contact lens use: remove lenses before administration to prevent drug retention. Corneal integrity: do not use on compromised cornea or active infection without physician guidance. Duration of use: limit exposure to the shortest time necessary to reduce risk of toxicity. Pediatric use: exercise caution; dosing and frequency should be determined by a qualified eye‑care professional. Store at room temperature: keep in original container, protect from light and moisture, and do not freeze.

Tetracaine ophthalmic solution may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic local anesthetics: concurrent use may increase risk of systemic toxicity. - Beta‑blocker eye drops: may potentiate ocular hypotensive effect. - Anticholinergic eye drops: may alter pupil response.

Moderate Interactions (Monitor Closely): - Topical antibiotics: monitor for increased irritation. - Other ophthalmic solutions: stagger administration to avoid dilution or reduced efficacy.